Revenue of the cold & cough remedies market worldwide by country 2018

This statistic depicts the revenue of the cold & cough remedies market in 2018, by country. In that year, the cold & cough remedies market revenue in the U.S. amounted to approximately 10,561.91 million U.S. dollars. For information on over 200 markets in 150 countries, please visit Consumer Market Outlook.

Revenue of the cold & cough remedies market worldwide by country in 2018

Exclusive Corporate Account feature

To view this statistic you need a Corporate Account, which includes the following benefits

  • Access to all content
  • Download as XLS, PPT, PNG and PDF
  • Detailed source and background information
Corporate Account
$700 per month*
(billed annually)
* All products require an annual contract.
   Prices do not include sales tax.
Show detailed source information?
Register for free
Already a member?
Log in

Supplementary notes

The cold and cough segment comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Use Statista now: unlimited access to all content

Statistics on "FMCG retail in Vietnam"

Use Statista now: unlimited access to all content
Learn more about how Statista can support your business.